Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Relay Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RLAY alerts

About Thomas Catinazzo

Thomas Catinazzo is recorded as CFO at Relay Therapeutics, Inc. (RLAY). The newest filing on record that lists Thomas Catinazzo as CFO at Relay Therapeutics, Inc. (RLAY) is dated April 28, 2026. The proxy statement of Relay Therapeutics, Inc. reports total compensation of $1,568,613 for Thomas Catinazzo in fiscal 2025, including a base salary of $486,100. Disclosed compensation is on record for 5 fiscal years. Relay Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relay Therapeutics, Inc. includes Brian R. Adams (General Counsel), Claire Mazumdar (Board Member), Douglas S. Ingram (Board Member) and 3 others.

Affiliation history

Company network

Leadership on record at Relay Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Relay Therapeutics, Inc. (RLAY) $486,100 $1,568,613
2024 Relay Therapeutics, Inc. (RLAY) $481,276 $4,400,994
2023 Relay Therapeutics, Inc. (RLAY) $465,000 $5,219,149
2022 Relay Therapeutics, Inc. (RLAY) $420,000 $2,457,265
2021 Relay Therapeutics, Inc. (RLAY) $381,100 $1,836,279

Recent activity

No call appearances or filed executive changes recorded yet.